We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VINC
4351
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$10K ﹤0.01%
31
+29
+1,450% +$8.46K
TBIO
4352
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$10K ﹤0.01%
+49
New +$12.4K
LSXMB
4353
DELISTED
Liberty Media Corporation Series B Liberty SiriusXM Common Stock
LSXMB
$10K ﹤0.01%
277
+224
+423% +$8.33K
CVIIU
4354
DELISTED
Churchill Capital Corp VII Units
CVIIU
$10K ﹤0.01%
+1,005
New +$9.99K
MAQC
4355
DELISTED
Maquia Capital Acquisition Corporation Class A Common Stock
MAQC
$10K ﹤0.01%
+985
New +$9.77K
DYNT
4356
DELISTED
Dynatronics Corp
DYNT
$10K ﹤0.01%
+1,383
New +$8.95K
VIA
4357
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$10K ﹤0.01%
196
-793
-80% -$44K
FUV
4358
DELISTED
Arcimoto, Inc. Common Stock
FUV
$10K ﹤0.01%
45
-23
-34% -$6.25K
NXTP
4359
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$10K ﹤0.01%
373
+127
+52% +$4.78K
BTTX
4360
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$10K ﹤0.01%
+1,052
New +$10.5K
LCA
4361
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
$10K ﹤0.01%
+1,045
New +$10.2K
ICVX
4362
DELISTED
Icosavax, Inc. Common Stock
ICVX
$10K ﹤0.01%
+334
New +$11.3K
CYAN
4363
DELISTED
Cyanotech Corp
CYAN
$10K ﹤0.01%
+3,474
New +$10.4K
AMTI
4364
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$10K ﹤0.01%
406
-1,175
-74% -$37.2K
EQRX
4365
DELISTED
EQRx, Inc. Common Stock
EQRX
$10K ﹤0.01%
1,000
+924
+1,216% +$9.25K
LFLY
4366
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$10K ﹤0.01%
49
+27
+123% +$5.38K
DMS
4367
DELISTED
Digital Media Solutions, Inc.
DMS
$10K ﹤0.01%
90
-233
-72% -$28.1K
HMPT
4368
DELISTED
Home Point Capital, Inc Common Stock
HMPT
$10K ﹤0.01%
2,439
+699
+40% +$3.22K
GLOP
4369
DELISTED
GASLOG PARTNERS LP
GLOP
$10K ﹤0.01%
+2,078
New +$8.98K
DSEY
4370
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
$10K ﹤0.01%
676
-9,894
-94% -$164K
DNAB
4371
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
$10K ﹤0.01%
+990
New +$9.75K
INDT
4372
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$10K ﹤0.01%
138
-203
-60% -$13.9K
RXDX
4373
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$10K ﹤0.01%
406
-593
-59% -$14K
LABP
4374
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$10K ﹤0.01%
65
-78
-55% -$10.1K
TA
4375
DELISTED
TravelCenters of America LLC
TA
$10K ﹤0.01%
206
-602
-75% -$22.5K

Similar funds

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.